Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

The assay effectively identifies compounds that affect immune cell activation.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

The study found that a one-step antibody method is better than the LSAB method for accurately studying hair follicle structures without false positives.

Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Combining cell conditioning with mild protease digestion effectively shows versican mRNA in mouse skin sections.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

A specific group of skin stem cells was found to help maintain hair follicle cells.

Selective breeding can enhance immunity in dairy cattle.

Increasing PDCD4 protein may help prevent or treat some skin cancers.